|
FANCI expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62825308791525E-12 |
| Normal-vs-Stage2 |
1.257200E-03 |
| Normal-vs-Stage3 |
8.34169999741619E-08 |
| Normal-vs-Stage4 |
2.775600E-03 |
| Stage1-vs-Stage2 |
3.298000E-01 |
| Stage1-vs-Stage3 |
9.247000E-04 |
| Stage1-vs-Stage4 |
6.809700E-02 |
| Stage2-vs-Stage3 |
1.999800E-01 |
| Stage2-vs-Stage4 |
1.808610E-01 |
| Stage3-vs-Stage4 |
6.121000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
5.97000004987081E-10 |
| Normal-vs-Asian |
3.498000E-02 |
| Caucasian-vs-AfricanAmerican |
8.890800E-01 |
| Caucasian-vs-Asian |
1.181400E-01 |
| AfricanAmerican-vs-Asian |
1.168400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.17594822768297E-12 |
| Male-vs-Female |
3.242500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.37999999894856E-09 |
| Normal-vs-Extreme_Weight |
7.71605002114484E-14 |
| Normal-vs-Obese |
1.45716771982052E-12 |
| Normal-vs-Extreme_Obese |
4.06600000000257E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.532230E-02 |
| Normal_Weight-vs-Obese |
8.832600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.942250E-03 |
| Extreme_Weight-vs-Obese |
4.323500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.732800E-01 |
| Obese-vs-Extreme_Obese |
5.828300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.582600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
5.77315972805081E-15 |
| Normal-vs-Age(81-100Yrs) |
1.200840E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.617900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.744200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.840410E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.295800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.579370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.564400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
2.38649988659745E-10 |
| Normal-VS-KIRP CIMP |
4.448800E-04 |
| Normal-VS-Unclassified PRCC |
5.10200000025662E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.589600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.464700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.091010E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.765100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.855400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.459360E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78100000303161E-08 |
| Normal-vs-N1 |
5.70680000033796E-07 |
| Normal-vs-N2 |
6.298300E-02 |
| N0-vs-N1 |
1.502230E-03 |
| N0-vs-N2 |
1.277220E-01 |
| N1-vs-N2 |
5.858600E-01 |
|
|
